Stock Events

Stock Events

ExpreS2ion Biotech AB 

SEK0.9340
6
+SEK0.00+0%Friday 11:37

Statistics

Day High
0.95
Day Low
0.934
52W High
19.54
52W Low
0.88
Volume
36,006
Avg. Volume
126,011
Mkt Cap
3.3M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 12Expected
Q3 2020
Q1 2024
Q2 2024
Q3 2024
Q1 2026
Q2 2026
Next
-0.3
0.03
0.37
0.7
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,041.43%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.66MRevenue
-38.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EXPRS2.ST. It's not an investment recommendation.
Novo Nordisk
5
NOVO-B.CO
Bavarian Nordic A/S
3
BAVA.CO
Vestas Wind Systems AS
2
VWS.CO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novavax
NVAX
Mkt Cap1.73B
Novavax is a biotechnology company developing vaccines, including for infectious diseases, directly competing with ExpreS2ion's focus on vaccine development.
Moderna
MRNA
Mkt Cap75.86B
Moderna is known for its mRNA technology used in vaccines, similar to ExpreS2ion's work on novel vaccine platforms.
BioNTech
BNTX
Mkt Cap24.34B
BioNTech competes in the space of developing vaccines using mRNA technology, similar to ExpreS2ion's focus areas.
Pfizer
PFE
Mkt Cap158.45B
Pfizer, in collaboration with BioNTech, has developed mRNA vaccines, placing it in direct competition with ExpreS2ion's vaccine development efforts.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson develops vaccines, including for infectious diseases, making it a competitor in the same market as ExpreS2ion.
Astrazeneca
AZN
Mkt Cap243.34B
AstraZeneca is involved in developing vaccines for various diseases, competing with ExpreS2ion's efforts in vaccine development.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline works on vaccines and therapeutics, including for infectious diseases, competing with ExpreS2ion's vaccine development projects.
Sanofi
SNY
Mkt Cap95.65B
Sanofi is engaged in vaccine development and production, making it a competitor in the same field as ExpreS2ion.
Inovio Pharmaceuticals
INO
Mkt Cap119.94M
Inovio Pharmaceuticals is involved in the development of DNA vaccines, a technology that competes with ExpreS2ion's vaccine development platforms.

About

Based in Horsholm, Denmark, ExpreS2ion Biotech Holding AB, along with its subsidiary ExpreS2ion Biotechnologies, specializes in creating and manufacturing complex proteins for use in vaccines and diagnostic products. The company's development pipeline includes a capsid virus-like particle COVID-19 vaccine, an influenza vaccine, and a breast cancer vaccine, all of which are currently undergoing Phase II clinical trials. ExpreS2ion is also engaged in developing a malaria vaccine. Furthermore, the company extends its reach by licensing its proprietary ExpreS2 platform to various research organizations and pharmaceutical businesses. ExpreS2ion Biotech Holding AB commenced operations in 2015.
Show More
CEO
Bent U. Frandsen
Employees
19
Country
Sweden
ISIN
SE0023261292
WKN
000A40P4H

Listings

MU
DE
5JD.MU
ST
SE
EXPRS2-BT-UN.ST
STU
DE
5JD0.STU
MU
DE
5JD0.MU

0 Comments

Share your thoughts

FAQs

What is ExpreS2ion Biotech AB stock price today?▼
The current price of EXPRS2.ST is SEK0.93 SEK — it has increased by +0% in the past 24 hours. Watch ExpreS2ion Biotech AB stock price performance more closely on the chart.
What is ExpreS2ion Biotech AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange ExpreS2ion Biotech AB stocks are traded under the ticker EXPRS2.ST.
Is ExpreS2ion Biotech AB stock price growing?▼
EXPRS2.ST stock has fallen by -11.05% compared to the previous week, the month change is a -19.83% fall, over the last year ExpreS2ion Biotech AB has showed a -94.48% decrease.
What is ExpreS2ion Biotech AB market cap?▼
Today ExpreS2ion Biotech AB has the market capitalization of 3.3M
When is the next ExpreS2ion Biotech AB earnings date?▼
ExpreS2ion Biotech AB is going to release the next earnings report on November 12, 2026.
What is ExpreS2ion Biotech AB revenue for the last year?▼
ExpreS2ion Biotech AB revenue for the last year amounts to 3.66M SEK.
What is ExpreS2ion Biotech AB net income for the last year?▼
EXPRS2.ST net income for the last year is -38.09M SEK.
How many employees does ExpreS2ion Biotech AB have?▼
As of November 1, 2026, the company has 19 employees.
In which sector is ExpreS2ion Biotech AB located?▼
ExpreS2ion Biotech AB operates in the Health & Wellness sector.
When did ExpreS2ion Biotech AB complete a stock split?▼
The last stock split for ExpreS2ion Biotech AB was on October 30, 2024 with a ratio of 1:40.
Where is ExpreS2ion Biotech AB headquartered?▼
ExpreS2ion Biotech AB is headquartered in Helsingborg, Sweden.